During the past decade, Multiple Centers conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Multiple Centers" are "Diabetic Peripheral Neuropathy" (1 trials), "Nerve Pain" (1 trials), "Neuralgia" (1 trials), "Neuropathy" (1 trials) and "PHN" (1 trials). Many other conditions were trialed in "Multiple Centers" in a lesser frequency.

Most popular intervention types in "Multiple Centers" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "EpiCept NP-1 (4% Amitriptyline/ 2% Ketamine) Topical Cream" (1 trials), "EpiCept-NP-1 Cream" (1 trials), "Gabapentin Capsules" (1 trials), "placebo" (1 trials) and "placebo cream" (1 trials). Other intervention names were less common.

The vast majority of trials in "Multiple Centers" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Multiple Centers". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Multiple Centers, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Multiple Centers, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".